These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21986835)
1. Cefepime-associated thrombocytopenia in a critically ill patient. Lim PP; Chong CP; Aziz NA Int J Clin Pharm; 2011 Dec; 33(6):902-4. PubMed ID: 21986835 [TBL] [Abstract][Full Text] [Related]
2. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study. Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639 [TBL] [Abstract][Full Text] [Related]
3. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime. Navalkele B; Pogue JM; Karino S; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Koons J; Hussain T; Perry W; Evans R; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Kaye KS Clin Infect Dis; 2017 Jan; 64(2):116-123. PubMed ID: 27986669 [TBL] [Abstract][Full Text] [Related]
4. Prospective monitoring of cefepime in intensive care unit adult patients. Chapuis TM; Giannoni E; Majcherczyk PA; Chioléro R; Schaller MD; Berger MM; Bolay S; Décosterd LA; Bugnon D; Moreillon P Crit Care; 2010; 14(2):R51. PubMed ID: 20359352 [TBL] [Abstract][Full Text] [Related]
5. Cefepime Associated With Phenytoin Induced Stevens-Johnson Syndrome. Marco-Del Río J; Domingo-Chiva E; Cuesta-Montero P; Valladolid-Walsh A; García-Martínez EM Am J Ther; 2017; 24(4):e481-e484. PubMed ID: 28692440 [TBL] [Abstract][Full Text] [Related]
6. Reversible coma secondary to cefepime neurotoxicity. Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986 [TBL] [Abstract][Full Text] [Related]
7. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309 [TBL] [Abstract][Full Text] [Related]
8. High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients. Goethaert K; Van Looveren M; Lammens C; Jansens H; Baraniak A; Gniadkowski M; Van Herck K; Jorens PG; Demey HE; Ieven M; Bossaert L; Goossens H Clin Microbiol Infect; 2006 Jan; 12(1):56-62. PubMed ID: 16460547 [TBL] [Abstract][Full Text] [Related]
9. A case of severe cefepime-related neutropenia in a 15-year-old patient. Malincarne L; Francisci D; Martinelli L; Masini G; Baldelli F Scand J Infect Dis; 2010; 42(2):156-7. PubMed ID: 19902990 [TBL] [Abstract][Full Text] [Related]
11. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Maganti R; Jolin D; Rishi D; Biswas A Epilepsy Behav; 2006 Feb; 8(1):312-4. PubMed ID: 16278098 [TBL] [Abstract][Full Text] [Related]
12. Clinical and electroencephalographic assessment of cefepime during treatment of nosocomial infections in neurological patients. Alvarez SD; Aragon Mdel C; Moreno A; Palomares-Alonso F; Cook HJ; Cardenas G; Soto-Hernandez JL Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):223-7. PubMed ID: 21919869 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients. Chaudhary M; Shrivastava SM; Varughese L; Sehgal R Curr Clin Pharmacol; 2008 May; 3(2):118-22. PubMed ID: 18700304 [TBL] [Abstract][Full Text] [Related]
14. Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody. Ruggero MA; Abdelghany O; Topal JE Pharmacotherapy; 2012 Nov; 32(11):e321-5. PubMed ID: 23065779 [TBL] [Abstract][Full Text] [Related]
15. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients. LeCleir LK; Pettit RS Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime. Smith NL; Freebairn RC; Park MA; Wallis SC; Roberts JA; Lipman J Crit Care Resusc; 2012 Dec; 14(4):312-5. PubMed ID: 23230881 [TBL] [Abstract][Full Text] [Related]
17. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients. Roberts JA; Webb SA; Lipman J Int J Antimicrob Agents; 2007 Feb; 29(2):117-28. PubMed ID: 17158033 [TBL] [Abstract][Full Text] [Related]
18. Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert. Cunningham JM; Sachs KV; Allyn R Am J Case Rep; 2020 Mar; 21():e921643. PubMed ID: 32147665 [TBL] [Abstract][Full Text] [Related]
19. Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study. Kim HS; Lee E; Cho YJ; Lee YJ; Rhie SJ J Clin Pharm Ther; 2019 Feb; 44(1):84-90. PubMed ID: 30243033 [TBL] [Abstract][Full Text] [Related]
20. Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case-Control Study. Singh TD; O'Horo JC; Day CN; Mandrekar J; Rabinstein AA Neurocrit Care; 2020 Dec; 33(3):695-700. PubMed ID: 32613426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]